Literature DB >> 10098546

Acquired convergence-evoked pendular nystagmus in multiple sclerosis.

J J Barton1, T A Cox, K B Digre.   

Abstract

Nystagmus seen only with convergence is unusual. We describe four cases of acquired convergence-evoked pendular nystagmus in patients with multiple sclerosis. The nystagmus was horizontal and asymmetric in all patients. Eye movement recordings in one subject showed a conjugate rather than a convergent-divergent relationship of the phase of movement between the two eyes. All patients had evidence of optic neuropathy and cerebellar dysfunction. Occlusion of either eye during fixation of near targets led to divergent drift of the covered eye and a decrease in nystagmus. Intravenous scopolamine reduced nystagmus in one patient. Base-in prisms alleviated symptoms of oscillopsia at near and improving reading visual acuity. Convergence-evoked pendular nystagmus may be more common than currently appreciated, particularly among patients with multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10098546

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  5 in total

Review 1.  Medical treatment of nystagmus and its visual consequences.

Authors:  John S Stahl; Gordon T Plant; R John Leigh
Journal:  J R Soc Med       Date:  2002-05       Impact factor: 5.344

Review 2.  What we know about the generation of nystagmus and other ocular oscillations: are we closer to identifying therapeutic targets?

Authors:  Rebecca Jane McLean; Irene Gottlob; Frank Antony Proudlock
Journal:  Curr Neurol Neurosci Rep       Date:  2012-06       Impact factor: 5.081

Review 3.  Nystagmus.

Authors:  J S Stahl; R J Leigh
Journal:  Curr Neurol Neurosci Rep       Date:  2001-09       Impact factor: 5.081

4.  Eye disorders in patients with multiple sclerosis: natural history and management.

Authors:  Jennifer Graves; Laura J Balcer
Journal:  Clin Ophthalmol       Date:  2010-12-06

5.  AhR-deficiency as a cause of demyelinating disease and inflammation.

Authors:  Ludmila Juricek; Julie Carcaud; Alice Pelhaitre; Thorfinn T Riday; Aline Chevallier; Justine Lanzini; Nicolas Auzeil; Olivier Laprévote; Florent Dumont; Sebastien Jacques; Frank Letourneur; Charbel Massaad; Cendra Agulhon; Robert Barouki; Mathieu Beraneck; Xavier Coumoul
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.